of Janus Investment Fund, a Massachusetts Business Trust (the Janus Fund) and (C) in the case of RA Capital Healthcare Fund, L.P. (RA Capital), such T. Rowe Price Investor, the Janus Fund and RA Capital may identify the Company and the value of its respective security holdings in the Company in accordance with applicable investment reporting and disclosure regulations and respond to routine examinations, demands, requests or reporting requirements of a regulator without prior notice to or consent from the Company.
The Company understands and acknowledges that (1) in the regular course of a T. Rowe Price Investors business, such T. Rowe Price Investor may invest in companies that have issued securities that are publicly traded (each, a Public Company), (2) in the regular course of its business, the Janus Fund may invest in Public Companies, (3) in the regular course of its business, RA Capital may invest in Public Companies and (4) in the regular course of its business, Rock Springs Capital Master Fund LP (Rock Springs) may invest in Public Companies. Accordingly, the Company covenants and agrees that before providing material non-public information about a Public Company (Public Company Information) (1) to a T. Rowe Price Investor, the Company will provide prior written notice to the following compliance personnel at such T. Rowe Price Investor describing such information in reasonable detail: Ryan Nolan, Vice President, firstname.lastname@example.org, 410-345-6618, or in his absence to John Gilner, Chief Compliance Officer, email@example.com, 410-345-2536, (2) to the Janus Fund, the Company will provide prior written notice to the following compliance personnel at the Janus Fund describing such information in reasonable detail: Janus Compliance Steven Andersen, Senior Compliance Manager, firstname.lastname@example.org, 303-394-7358, or in his absence, David Kowalski, Chief Compliance Officer, email@example.com, 303-316-5747, (3) to RA Capital, the Company will provide prior written notice to the following compliance personnel at RA Capital describing such information in reasonable detail: Derek Meisner, General Counsel and Chief Compliance Officer, firstname.lastname@example.org, with a copy to Nicholas McGrath, Corporate Counsel and Compliance Officer, email@example.com, and (4) to Rock Springs, the Company will provide prior written notice to the following compliance personnel at Rock Springs describing such information in reasonable detail: Graham McPhail, Managing Director, firstname.lastname@example.org, 410-220-0127. The Company shall not disclose Public Company Information to any T. Rowe Price Investor, the Janus Fund or Rock Springs without written authorization from the applicable compliance personnel listed above, provided, however, that, the Company will be permitted to disclose agreements entered into with Public Companies in the ordinary course of business, such as routine customer, supplier, advertising and publishing agreements without such written authorization.
4. Rights to Future Stock Issuances.
4.1 Right of First Offer. Subject to the terms and conditions of this Subsection 4.1 and applicable securities laws, if the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to the Investors. Each Investor shall be entitled to apportion the right of first offer hereby granted to it in such proportions as it deems appropriate, among (i) itself, (ii) its Affiliates and (iii) its beneficial interest holders, such as limited partners, members or any other Person having beneficial ownership, as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of such Investor (Investor Beneficial Owners); provided that each such Affiliate or Investor Beneficial Owner agrees to enter into this Agreement as an Investor.